MCAM is a long-acting medication that can prevent opioid overdose by blocking the effects of opioids for days or even weeks.

Boston has hit a tipping point. City taxpayers deserve a coordinated response by the State Police, Boston Police, DEA, FBI, ...

The U.S. Food and Drug Administration sent letters to seven companies that sell opioid alternative products containing ...

The Food and Drug Administration is taking a closer look at kratom extracts and preparing to ask Congress for expanded ...

R ICHMOND, Va. (WRIC) — The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to severe acute pain in more than 20 years.

Attorney General Alan Wilson announced approximately $720 million nationwide in settlements with eight drug makers that ...

Companies that manufacture powerful, long-acting opioid painkillers will have to sponsor education programs about how to appropriately prescribe their drugs, according to the FDA.

WASHINGTON (AP) — As U.S. opioid deaths mounted in 2016, the incoming head of the Food and Drug Administration promised a “sweeping review” of prescription painkillers in hopes of reversing ...

The FDA approved the first new class of non-opioid painkillers in more than two decades, the agency said Thursday. Suzetrigine, branded as Journavx, works to block receptors before they reach the ...